Notice Regarding Changes of Representative Directors and Directors
Filed with TSE · · 4 pages · English
MEDIPAL HOLDINGS CORPORATION (the “Company”) hereby announces the following decisions regarding changes to our Representative Director and Directors, effective October 1, 2026. 1. Change of Representative Directors Today (September 8, 2026), following deliberation by the Nomination Committee, a resolution was adopted by the Board of Directors. (1) Reason for Change (2) Change in Position and Assig
Medipal Holdings Corporation on 6ix
Story so far
Earlier from Medipal
- Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2027
- Notice Regarding Revision of Full-Year Consolidated Financial Forecasts
- Notice Regarding Results of the Tender Offer for Shares of PALTAC CORPORATION (Securities Code: 8283)
- Medipal Holdings: Consolidated Financial Statements for the Fiscal Year Ended March 31, 2026
- Notice Regarding Dividends of Retained Earnings (Dividend Increase)
Later from Medipal
- Notice Regarding Setting of Record Date for Convocation of an Extraordinary General Meeting of Shareholders
- Notice Regarding Decision on Matters Concerning Acquisition of Treasury Stock and Cancellation of Treasury Stock
- Notice Regarding Recording of Gain on Sale of Investment Securities (Extraordinary Income)
- Notice Regarding Shareholder’s Petition for Permission to Convene an Extraordinary General Meeting of Shareholders
Follow Medipal into a list and get an email when it puts out news.
Follow Medipal